drugset / Trial / NCT05519202
Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
To explore the efficacy and safety of Penpulimab combined with SOX in the perioperative treatment of gastric cancer
Timeline
- Start
- 2022-08-31
- Primary completion
- 2023-08-31
- Completion
- 2024-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | 130 mg/m2 | — |
| Subject | Penpulimab | Monoclonal antibody | 200 mg | Intravenous |
| Subject | S-1 | Small molecule | 40 mg/m2 | Oral |